首页> 外国专利> Procedure for the inversion of the stereochemistry at C13 of avermectin aglycone compounds

Procedure for the inversion of the stereochemistry at C13 of avermectin aglycone compounds

机译:阿维菌素糖苷配基化合物在C13处的立体化学转化步骤

摘要

The natural stereochemistry at the 13-position of avermectin aglycones, normally α-oriented or below the plane of the molecule, is inverted or epimerized into the β-position. The procedure starts with the avermectin aglycone compounds where the 13α-hydroxy group is substituted with a leaving group. Treatment of the substituted compound with tetra alkyl ammonium nitrate displaces the leaving group, substitutes a nitrate ester or a nitrooxy group, for the hydroxy and inverts the 13-stereochemistry to β. Reduction of the nitrooxy group returns the 13-hydroxy group and retains the 13-β configuration. The intermediate 13-nitrooxy compounds are themselves potent anti-parasitic agents.
机译:阿维菌素糖苷配基的13位(通常为α取向或分子平面以下)的自然立体化学被反转或差向β位。该过程开始于阿维菌素糖苷配基化合物,其中13α-羟基被离去基团取代。用硝酸四烷基铵处理取代的化合物取代了离去基团,用硝酸酯或硝基氧基取代了羟基,并将13-立体化学转化为β。硝基氧基的还原返回13-羟基并保留13-β构型。中间体13-硝基氧基化合物本身就是有效的抗寄生虫剂。

著录项

  • 公开/公告号EP0514090A1

    专利类型

  • 公开/公告日1992-11-19

    原文格式PDF

  • 申请/专利权人 MERCK & CO. INC.;

    申请/专利号EP19920304151

  • 发明设计人 JONES TODD K.;MROZIK HELMUT;

    申请日1992-05-08

  • 分类号C07H19/01;C07D493/22;A01N43/90;A61K31/70;

  • 国家 EP

  • 入库时间 2022-08-22 05:06:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号